Vaxart

VXRT NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $2,181 $3,245 $446 $1,358
Gross Profit 1,081 2,045 -754 231
EBITDA -22,970 -15,700 -15,089 -20,176
EBIT -24,070 -16,900 -17,154 -22,342
Net Income -24,417 -17,375 -17,400 -22,550
Net Change In Cash 2,181 3,245 446 1,358
Cost of Revenue -5,157
Free Cash Flow -21,322 -13,417 -15,283 -17,925
Cash 26,735 34,755 32,448 43,277
Basic Shares 168,811 153,452 152,026 139,594

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $7,379 $107 $892 $4,046
Gross Profit 2,879 -3,160 -47,857 -15,817
EBITDA -78,847 -96,321 -61,669 -28,234
EBIT -83,347 -102,126 -65,877 -30,944
Net Income -82,465 -107,758 -70,470 -32,220
Net Change In Cash 7,379 107 892 4,046
Cost of Revenue -97,732 16,875 113,344
Free Cash Flow -72,324 -104,380 -64,989 -24,973
Cash 34,755 44,013 143,745 126,870
Basic Shares 144,819 127,683 121,453 88,295

Earnings Calls

Quarter EPS
2024-03-31 -$0.14
2023-12-31 -$0.12
2023-09-30 -$0.11
2023-06-30 -$0.16